KyooH.LeeMD

Anesthesiology • Elgin, IL

Pain Medicine

Physician

Join to view full profile

Are you Dr. Lee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
77 N Airlite St
Elgin, IL 60123
Phone+1 847-695-3200

Summary

Dr. Kyoo Lee, MD is an anesthesiologist in Elgin, Illinois.

Education & Training

Mount Sinai Hospital Medical Center of ChicagoResidency, Anesthesiology, 1970 - 1973
St Francis Medical CenterInternship, Transitional Year, 1969 - 1970
Seoul National University College of MedicineClass of 1966

Certifications & Licensure

American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease Start of enrollment: 2004 Apr 01
Completed
Not Applicable
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant Start of enrollment: 2007 May 01
Completed
Phase 1
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2005 Oct 01
Completed
Phase 2
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer Start of enrollment: 2003 Jan 01
Completed
Phase 2
Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome Start of enrollment: 2008 Apr 01
Completed
Phase 2
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome Start of enrollment: 2008 Apr 01
Completed
Phase 2
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Start of enrollment: 2009 Jan 01
Completed
Phase 1, Phase 2
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2009 Jan 01
Completed
Phase 2
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission Start of enrollment: 2011 May 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

6 citations
Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
Jun-Hong Park, Je-Hwan Lee, Jung-Hee Lee, Han Seung Park, Eun-Ji Choi
Journal of Korean Medical Science. 2021-05-12
24 citations
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
Su Jin Lee, Chul Won Jung, Dae-Young Kim, Kyoo Hyung Lee, Sang Kyun Sohn
American Journal of Hematology. 2011-04-01
41 citations
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia
Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Sung-Doo Kim, Sung Nam Lim
Leukemia Research. 2011-02-01